Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
5.63
-0.31 (-5.22%)
Dec 5, 2025, 4:00 PM EST - Market closed
Armata Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 5.05 | 5.17 | 4.53 | 5.51 | 4.47 | 0.82 | |
| Revenue Growth (YoY) | -7.55% | 14.24% | -17.77% | 23.11% | 443.62% | - | |
| Cost of Revenue | 26.1 | 34.43 | 33.77 | 35.02 | 20.02 | 14.44 | |
| Gross Profit | -21.04 | -29.25 | -29.24 | -29.51 | -15.54 | -13.62 | |
| Selling, General & Admin | 12.31 | 13.18 | 11.65 | 7.44 | 8.28 | 7.97 | |
| Operating Expenses | 12.31 | 13.18 | 11.65 | 7.44 | 8.28 | 7.97 | |
| Operating Income | -33.35 | -42.44 | -40.89 | -36.95 | -23.82 | -21.59 | |
| Interest Expense | -15.04 | -10.74 | -2.63 | - | -0.06 | -0.63 | |
| Interest & Investment Income | 0.39 | 0.7 | 0.18 | 0.03 | 0.01 | 0.03 | |
| Other Non Operating Income (Expenses) | - | - | - | - | - | 0.01 | |
| EBT Excluding Unusual Items | -48 | -52.48 | -43.34 | -36.92 | -23.88 | -22.18 | |
| Other Unusual Items | 1.1 | 33.57 | -25.71 | - | 0.73 | - | |
| Pretax Income | -46.9 | -18.92 | -69.05 | -36.92 | -23.16 | -22.18 | |
| Net Income | -46.9 | -18.92 | -69.05 | -36.92 | -23.16 | -22.18 | |
| Net Income to Common | -46.9 | -18.92 | -69.05 | -36.92 | -23.16 | -22.18 | |
| Shares Outstanding (Basic) | 36 | 36 | 36 | 34 | 24 | 16 | |
| Shares Outstanding (Diluted) | 36 | 59 | 36 | 34 | 24 | 16 | |
| Shares Change (YoY) | 0.16% | 63.71% | 5.20% | 42.27% | 46.84% | 104.93% | |
| EPS (Basic) | -1.30 | -0.52 | -1.91 | -1.08 | -0.96 | -1.35 | |
| EPS (Diluted) | -2.22 | -0.89 | -1.91 | -1.08 | -0.96 | -1.35 | |
| Free Cash Flow | -27.43 | -39.43 | -55.57 | -34.69 | -24.88 | -19.09 | |
| Free Cash Flow Per Share | -0.76 | -0.67 | -1.54 | -1.01 | -1.03 | -1.16 | |
| Operating Margin | -659.87% | -820.18% | -902.85% | -670.77% | -532.45% | -2622.97% | |
| Profit Margin | -928.00% | -365.60% | -1524.51% | -670.24% | -517.55% | -2695.14% | |
| Free Cash Flow Margin | -542.72% | -762.08% | -1226.91% | -629.85% | -556.08% | -2320.05% | |
| EBITDA | -31.86 | -41.11 | -39.92 | -36.05 | -22.65 | -20.47 | |
| D&A For EBITDA | 1.49 | 1.33 | 0.97 | 0.89 | 1.17 | 1.11 | |
| EBIT | -33.35 | -42.44 | -40.89 | -36.95 | -23.82 | -21.59 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.